Table 1

The clinical outcomes of glaucomatous eyes in the series

Patient	Eye	Timing of surgery (days)	Glaucoma onset (days)	Presenting sign	1st line of treatment	2nd line of treatment and 5 year visual outcomes (logMAR)	Other features
1†	right	79	12	Corneal oedema, OHT	Vitrectomy	Medication not required after vitrectomy, vision 0.8
2	right	14*	37	Corneal oedema, OHT	Vitrectomy Medication	Trabeculotomy, cyclodiode ×2, Vision NPL	c/d ratio 0.7
2	left	16*	40	Corneal oedema, OHT	Vitrectomy Medication	Cyclodiode ×2, vision PL	PAS, c/d ratio 0.55
3	right	42	46	OHT	Vitrectomy	Weaned off medication after vitrectomy within first year, vision missing	PAS
4	left	10*	70	Corneal oedema, OHT	Vitrectomy Medication	Goniotomy, trabeculectomy, cyclodiode ×2, Ahmed tube, vision HM	c/d ratio 1.0
5	right	27*	85	Corneal oedema, OHT	Vitrectomy Medication	Trabeculectomy, vision 0.9
6	left	79	334	Corneal oedema, OHT	Medication	Vitrectomy, vision 0.8
7	right	95	490	Corneal oedema, OHT	Medication	Cyclodiode, vision 0.5
8	right	39	695	Corneal oedema, OHT	Medication	Cyclodiode, vision 1.5	Myopic shift, PAS
9	left	26*	800	OHT	Medication	Vision 0.1	PAS
9	right	14*	812	OHT	Medication	Vision 0.3
10	left	15*	1013	Not available	Not available	Trabeculectomy, cyclodiode, vision 0.8	Not available
11†	left	20*	1111	OHT	Medication	Vision 0.5	c/d ratio 0.5
12	right	11*	1185	OHT	Medication	Cyclodiode, vision 0.2
8	left	88	1213	Not available	Not available	Cyclodiode, vision 0.3	Not available
13	right	79	1305	OHT	Medication	Vision 0.6
14	left	29*	1370	OHT	Medication	Vision 0.2	PAS, c/d ratio 0.55
15	left	108	1382	OHT	Medication	Vision 0.8	c/d ratio 0.5
15	Right	95	1416	OHT	Medication	Vision 1.0	PAS
12	Left	13*	1644	Not available	Not available	Vision 0.8	Not available
13	Left	71	1735	OHT	Medication	Vision 0.7